Investing.com - MustGrow Biologics reported on Thursday third quarter earnings that missed analysts' forecasts and revenue that topped expectations.
MustGrow Biologics announced earnings per share of C$-0.03 on revenue of C$3.72K. Analysts polled by Investing.com EPS of C$-0.01 on revenue of C$0.00.
MustGrow Biologics 's are down 57% and is trading at C$2.63 , still down 53.04% from its 52 week high of C$5.60 set on Tuesday, October 26, 2021.
MustGrow Biologics follows other major Healthcare sector earnings this month
MustGrow Biologics's report follows an earnings missed by Curaleaf on Monday, August 8, 2022, who reported EPS of C$-0.04 on revenue of C$337.55M, EPS of C$-0.038 on revenue of C$333.81M.
Trulieve Cannabis had missed expectations on Wednesday, August 10, 2022 with second quarter EPS of C$-0.12 on revenue of C$320.3M, for EPS of C$-0.008 on revenue of C$321.64M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar